James E. Flynn 13D and 13G filings for Kura Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-12 5:33 pm Purchase | 2023-12-31 | 13G | Kura Oncology, Inc. KURA | James E. Flynn | 5,312,733 7.150% | 938,689 (+21.46%) | Filing |
| 2023-09-21 4:55 pm Purchase | 2023-09-14 | 13G | Kura Oncology, Inc. KURA | James E. Flynn | 4,374,044 5.890% | 1,991,044 (+83.55%) | Filing |
| 2023-02-10 10:05 am Sale | 2022-12-31 | 13G | Kura Oncology, Inc. KURA | James E. Flynn | 2,383,000 3.560% | -1,130,756 (-32.18%) | Filing |
| 2021-12-03 3:07 pm Purchase | 2021-11-29 | 13G | Kura Oncology, Inc. KURA | James E. Flynn | 3,513,756 5.280% | 3,513,756 (New Position) | Filing |